Skip to main content
. 2020 Jan 9;1(2):123–126. doi: 10.34067/KID.0000502019

Table 1.

Current or previously approved gadolinium-based contrast agents and their manufacturer, chemical structure and ionicity, American College of Radiology classification, and Canadian Association of Radiologists risk assessment

Gadolinium Agent Manufacturer Chemical Structure ACR Classification CAR Risk Assessment
Gadodiamide GE Healthcare Linear nonionic Group 1 High risk
Gadoversetamide Guerbet Linear nonionic Group 1 High risk
Gadopentetate dimeglumine Bayer AG Linear ionic Group 1 High risk
Gadobutrol Bayer Healthcare/Bayer AG Macrocyclic nonionic Group 2 Low risk
Gadoteridol Bracco Diagnostics Macrocyclic nonionic Group 2 Low risk
Gadoterate meglumine Guerbet Macrocyclic ionic Group 2 Low risk
Gadobenate dimeglumine Bracco Diagnostics Linear ionic Group 2 Medium risk
Gadoxetate disodium Bayer Healthcare Linear ionic Group 3 Medium risk

ACR, American College of Radiology; CAR, Canadian Association of Radiologists.